Lassi Nelimarkka

- Clinical Lecturer,
Internal Medicine (Department of Clinical Medicine)

lassinel@utu.fi

SGLT2:n estäjien käyttö yleistyy – muista harvinaiset haitat (2024)
- Duodecim
Hellman Tapio, Nelimarkka Lassi, Niskanen Leo, Juonala Markus
Dysphagia, hypothyroidism, and osteoradionecrosis after radiation therapy for head and neck cancer (2022)
- Laryngoscope Investigative Otolaryngology
Ranta Pihla, Kytö Eero, Nissi Linda, Kinnunen Ilpo, Vahlberg Tero, Minn Heikki, Haapio Eeva, Nelimarkka Lassi, Irjala Heikki
Hyperkolesterolemian uudet hoitosuositukset (2021)
- Erikoislääkäri
Nelimarkka Lassi, Juonala Markus
Diabeetikon ajoterveys (2020)
- Erikoislääkäri
Nelimarkka Lassi, Järveläinen Hannu
The relationship between diurnal cortisol secretion and climacteric-related symptoms (2018)
- Maturitas
Riina Katainen, Nea Kalleinen, Simo Teperi, Tero Vahlberg, Ursula Turpeinen, Esa Hämäläinen, Lassi Nelimarkka, Päivi Polo-Kantola
Diabeteksen lääkehoito (2017)
- Erikoislääkäri
Nelimarkka Lassi, Valle Timo
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome (2015)
- New England Journal of Medicine
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; for the ELIXA Investigators
Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery (2015)
- Diabetologia
Makinen J, Hannukainen JC, Karmi A, Immonen HM, Soinio M, Nelimarkka L, Savisto N, Helmio M, Ovaska J, Salminen P, Iozzo P, Nuutila P
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo (2015)
- American Heart Journal
Bentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P, Køber LV, Lawson F, Lewis EF, Maggioni AP, McMurray JJ, Ping L, Probstfield JL, Solomon SD, Tardif JC, Wu Y, Pfeffer MA; for the ELIXA Investigators
Planar Scintigraphy with I-123/Tc-99m-Sestamibi, Tc-99m-Sestamibi SPECT/CT, C-11-Methionine PET/CT, or Selective Venous Sampling Before Reoperation of Primary Hyperparathyroidism? (2013)
- Journal of Nuclear Medicine
Schalin-Jantti C, Ryhanen E, Heiskanen I, Seppanen M, Arola J, Schildt J, Vaisanen M, Nelimarkka L, Lisinen I, Aalto V, Nuutila P, Valimaki MJ
Ketoasidoosin hoito (2012)
- Lääkärilehti
Nelimarkka L, Arola OJ
Intestinal insulin resistance associated with obesity and type 2 diabetes (2011)
- Diabetologia
MINUTES OF THE 46th GENERAL ASSEMBLY OF THE EUROPEAN Makinen J, Karmi A, Hannukainen JC, Immonen HM, Soinio M, Nelimarkka L, Salminen P, Nuutila P
Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor (2003) Iivanainen E, Nelimarkka L, Elenius V, Heikkinen S-M, Junttila TT, Sihombin L, Sundvall M, Määttä JA, Laine VJO, Higashiyama S, Alitalo K, Elenius K